|
1
|
Li H, Liu Y, Guo S, Shi M, Qin S and Zeng
C: Extraction of ursolic acid from apple peel with hydrophobic deep
eutectic solvents: Comparison between response surface methodology
and artificial neural networks. Foods. 9(310)2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Yamaguchi H, Noshita T, Kidachi Y, Umetsu
H, Hayashi M, Komiyama K, Funayama S and Ryoyama K: Isolation of
ursolic acid from apple peels and its specific efficacy as a potent
antitumor agent. J Health Sci. 54:654–660. 2008.
|
|
3
|
Seo DY, Lee SR, Heo JW, No MH, Rhee BD, Ko
KS, Kwak HB and Han J: Ursolic acid in health and disease. J
Physiol Pharmacol. 25:235–248. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Murakami A, Kuki W, Takahashi Y, Yonei H,
Nakamura Y, Ohto Y, Ohigashi H and Koshimizu K: Auraptene, a citrus
coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced
tumor promotion in ICR mouse skin, possibly through suppression of
superoxide generation in leukocytes. Jpn J Cancer Res. 88:443–452.
1997.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Silalahi J: Anticancer and health
protective properties of citrus fruit components. Asia Pac J Clin
Nutr. 11:79–84. 2002.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Huang YS and Ho SC: Polymethoxy flavones
are responsible for the anti-inflammatory activity of citrus fruit
peel. Food Chem. 119:868–873. 2010.
|
|
7
|
Tripoli E, Guardia ML, Giammanco S, Majo
DD and Giammanco M: Citrus flavonoids: Molecular structure,
biological activity and nutritional properties: A review. Food
Chem. 104:466–479. 2007.
|
|
8
|
Nakajima VM, Macedo GA and Macedo JA:
Citrus bioactive phenolics: Role in the obesity treatment. LWT-Food
Sci Technol. 59:1205–1212. 2014.
|
|
9
|
Castillero E, Alamdari N, Lecker SH and
Hasselgren PO: Suppression of atrogin-1 and MuRF1 prevents
dexamethasone-induced atrophy of cultured myotubes. Metabolism.
62:1495–1502. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ebert SM, Dyle MC, Bullard SA, Dierdorff
JM, Murry DJ, Fox DK, Bongers KS, Lira VA, Meyerholz DK, Talley JJ
and Adams CM: Identification and small molecule inhibition of an
activating transcription factor 4 (ATF4)-dependent pathway to
age-related skeletal muscle weakness and atrophy. J Biol Chem.
290:25497–25511. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Alfei S, Marengo B, Valenti GE and Zuccari
G: Considerable improvement of ursolic acid water solubility by its
encapsulation in dendrimer nanoparticles. Nanomaterials.
11(2196)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mazurek AH and Szeleszczuk Ł: Current
status of quantum chemical studies of cyclodextrin host-guest
complexes. Molecules. 27(3874)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kfoury M, Landy D and Fourmentin S:
Characterization of cyclodextrin/volatile inclusion complexes: A
review. Molecules. 23(1204)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Loftsson T, Sigurdsson HH and Jansook P:
Anomalous properties of cyclodextrins and their complexes in
aqueous solutions. Materials (Basel). 16(2223)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sarabia-Vallejo Á, Caja MDM, Olives AI,
Martín MA and Menéndez JC: Cyclodextrin inclusion complexes for
improved drug bioavailability and activity: Synthetic and
analytical aspects. Pharmaceutics. 15(2345)2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Patel HA, Islamoglu T, Liu Z, Nalluri SKM,
Samanta A, Anamimoghadam O, Malliakas CD, Farha OK and Stoddart JF:
Noninvasive substitution of K+ sites in cyclodextrin metal organic
frameworks by Li+ ions. J Am Chem Soc. 139:11020–11023.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Benedetto G, Cleary BM, Morrell CT, Durbin
C, Brinks AL, Tietjen J and Mirica KA: CD-MOF-1 for CO2
uptake: Remote and hybrid green chemistry synthesis of a framework
material with environmentally conscious applications. J Chem Educ.
100:1289–1295. 2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nanri A, Yoshida M, Ishida Y, Nakata D,
Terao K, Arce FJ, See GL, Tanikawa T and Inoue Y: Preparation and
characterization of a hybrid complex of cyclodextrin-based
metal-organic frameworks-1 and ascorbic acid derivatives. Materials
(Basel). 14(7309)2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang N, Wei L, Teng Y, Yu P, Xiang C and
Liu J: Cyclodextrin-based metal-organic frameworks transforming
drug delivery. Eur J Med Chem. 274(116546)2024.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Inoue Y, Motoda A, Tanikawa T, Takao K,
Arce F Jr, See GL, Ishida Y, Nakata D and Terao K: Inclusion
complexes of ursolic acid with cyclodextrin-based metal-organic
framework-1 enhance its solubility. J Drug Deliv Sci Technol.
89(104986)2023.
|
|
21
|
Waage A, Slupphaug G and Shalaby R:
Glucocorticoids inhibit the production of IL6 from monocytes,
endothelial cells and fibroblasts. Eur J Immunol. 20:2439–2443.
1990.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yu R, Chen JA, Xu J, Cao J, Wang Y, Thomas
SS and Hu Z: Suppression of muscle wasting by the plant-derived
compound ursolic acid in a model of chronic kidney disease. J
Cachexia Sarcopenia Muscle. 8:327–341. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kunkel SD, Elmore CJ, Bongers KS, Ebert
SM, Fox DK, Dyle MC, Bullard SA and Adams CM: Ursolic acid
increases skeletal muscle and brown fat and decreases diet-induced
obesity, glucose intolerance and fatty liver disease. PLoS One.
7(e39332)2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Rommel C, Bodin SC, Clarke BA, Rossman R,
Nunez L, Stitt TN, Yancopoulos GD and Glass DJ: Mediation of
IGF-1-induced skeletal myotube hypertrophy by PI3K/Akt/mTOR and
PI3K/Akt/GSK3 pathways. Nat Cell Biol. 3:1009–1013. 2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ebert SM, Nicolas CS, Schreiber P, Lopez
JG, Taylor AT, Judge AR, Judge SM, Rasmussen BB, Talley JJ, Rème CA
and Adams CM: Ursolic acid induces beneficial changes in skeletal
muscle mRNA expression and increases exercise participation and
performance in dogs with age-related muscle atrophy. Animals
(Basel). 14(186)2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Song S, Gao K, Niu R, Yi W, Zhang J, Gao
C, Yang B and Liao X: Binding behavior, water solubility and in
vitro cytotoxicity of inclusion complexes between ursolic acid and
amino-appended β-cyclodextrins. J Mol Liquids.
296(111993)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zong W and Mei BS: The Preparation and
characterization of inclusion complex of ursolic acid with
γ-Cyclodextrin. Adv Mater Res. 403-408:712–716. 2011.
|
|
28
|
Hartlieb KJ, Ferris DP, Holcroft JM,
Kandela I, Stern CL, Nassar MS, Botros YY and Stoddart JF:
Encapsulation of ibuprofen in CD-MOF and related bioavailability
studies. Mol Pharm. 14:1831–1839. 2017.PubMed/NCBI View Article : Google Scholar
|
